Perspective Therapeutics announced that it has commenced an underwritten public offering of shares of its common stock, and, to certain investors in lieu of common stock, pre-funded warrants to purchase shares of its common stock. Oppenheimer & Co. and B. Riley Securities are acting as joint book-running managers for the public offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CATX:
- Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01
- Perspective Therapeutics enters strategic agreements with Lantheus
- Lantheus expands radiopharmaceutical oncology pipeline via agreements
- Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability
- Perspective Therapeutics announces exclusive license agreement with Mayo Clinic
